SARS-CoV-2-N-glycan

Leili Baghaie1, Fleur Leroy2, Mehdi Sheikhi3,4

  • 1Department of Biomedical & Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.

Viruses
|October 28, 2023
PubMed
概括

病毒突变可以逃避免疫反应,但现有的疫苗和助推剂仍然可以提供对新型SARS-CoV-2变异的保护. 持续接种疫苗对于预防进一步的突变和开发改进的疫苗至关重要.